Pfizer Net Cash Flow from Financing vs Net Cash Flow Business Acquisitions and Disposals Analysis

PFE
 Stock
  

USD 49.78  0.21  0.42%   

Pfizer financial indicator trend analysis is much more than just breaking down Pfizer Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pfizer Inc is a good investment. Please check the relationship between Pfizer Net Cash Flow from Financing and its Net Cash Flow Business Acquisitions and Disposals accounts. Please check Your Equity Center.

Net Cash Flow from Financing vs Net Cash Flow Business Acquisitions and Disposals

Net Cash Flow from Financing vs Net Cash Flow Business Acquisitions and Disposals Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pfizer Inc Net Cash Flow from Financing account and Net Cash Flow Business Acquisitions and Disposals. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Pfizer's Net Cash Flow from Financing and Net Cash Flow Business Acquisitions and Disposals is -0.39. Overlapping area represents the amount of variation of Net Cash Flow from Financing that can explain the historical movement of Net Cash Flow Business Acquisitions and Disposals in the same time period over historical financial statements of Pfizer Inc, assuming nothing else is changed. The correlation between historical values of Pfizer's Net Cash Flow from Financing and Net Cash Flow Business Acquisitions and Disposals is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Cash Flow from Financing of Pfizer Inc are associated (or correlated) with its Net Cash Flow Business Acquisitions and Disposals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Cash Flow Business Acquisitions and Disposals has no effect on the direction of Net Cash Flow from Financing i.e., Pfizer's Net Cash Flow from Financing and Net Cash Flow Business Acquisitions and Disposals go up and down completely randomly.

Correlation Coefficient

-0.39
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Cash Flow from Financing

A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from financing activities; from continuing and discontinued operations. Principal components of financing cash flow are: issuance (purchase) of equity shares; issuance (repayment) of debt securities; and payment of dividends & other cash distributions.

Net Cash Flow Business Acquisitions and Disposals

A component of Net Cash Flow from Investing representing the net cash inflow (outflow) associated with the acquisition & disposal of businesses; joint-ventures; affiliates; and other named investments.
Most indicators from Pfizer fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pfizer Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please check Your Equity Center.Pfizer Issuance Repayment of Debt Securities is projected to based on the last few years of reporting. The past year's Issuance Repayment of Debt Securities was at 7.89 Billion. The current year Net Cash Flow Investment Acquisitions and Disposals is expected to grow to about 11.5 B, whereas Net Cash Flow Business Acquisitions and Disposals is forecasted to decline to (13.5 B).
 2019 2021 2022 (projected)
Consolidated Income16.3 B18.75 B17.02 B
Direct Expenses10.22 B30.82 B33.25 B

Pfizer fundamental ratios Correlations

0.360.660.24-0.090.48-0.280.810.580.490.170.340.61-0.59-0.730.130.240.76-0.350.650.410.170.21-0.46
0.360.060.90.730.310.330.16-0.20.470.910.170.360.190.140.030.50.130.33-0.070.610.820.80.25
0.660.060.11-0.050.04-0.160.720.660.06-0.040.180.13-0.8-0.76-0.20.280.83-0.540.78-0.1-0.31-0.23-0.57
0.240.90.110.730.20.320.18-0.070.240.880.140.220.150.09-0.030.740.210.280.030.440.60.590.29
-0.090.73-0.050.73-0.320.4-0.1-0.32-0.020.85-0.36-0.080.440.44-0.030.25-0.080.12-0.260.160.430.430.21
0.480.310.040.2-0.32-0.20.30.010.780.110.840.79-0.14-0.170.110.240.080.520.250.780.560.40.32
-0.280.33-0.160.320.4-0.2-0.41-0.31-0.330.32-0.21-0.390.290.260.080.17-0.210.26-0.66-0.150.210.170.27
0.810.160.720.18-0.10.3-0.410.870.340.080.090.43-0.5-0.830.360.250.76-0.540.740.11-0.15-0.15-0.59
0.58-0.20.66-0.07-0.320.01-0.310.87-0.1-0.24-0.130.07-0.56-0.920.370.190.72-0.730.64-0.31-0.55-0.5-0.69
0.490.470.060.24-0.020.78-0.330.34-0.10.320.620.86-0.05-0.030.020.020.020.350.290.870.70.560.1
0.170.91-0.040.880.850.110.320.08-0.240.32-0.030.220.380.30.080.34-0.030.22-0.160.460.690.650.21
0.340.170.180.14-0.360.84-0.210.09-0.130.62-0.030.63-0.41-0.12-0.430.310.080.550.390.680.440.360.38
0.610.360.130.22-0.080.79-0.390.430.070.860.220.63-0.15-0.160.030.120.180.290.430.880.530.330.18
-0.590.19-0.80.150.44-0.140.29-0.5-0.56-0.050.38-0.41-0.150.790.46-0.24-0.680.42-0.80.050.320.170.47
-0.730.14-0.760.090.44-0.170.26-0.83-0.92-0.030.3-0.12-0.160.79-0.16-0.24-0.780.63-0.710.160.40.30.67
0.130.03-0.2-0.03-0.030.110.080.360.370.020.08-0.430.030.46-0.16-0.170.02-0.2-0.3-0.12-0.07-0.17-0.2
0.240.50.280.740.250.240.170.250.190.020.340.310.12-0.24-0.24-0.170.460.250.290.230.220.240.29
0.760.130.830.21-0.080.08-0.210.760.720.02-0.030.080.18-0.68-0.780.020.46-0.550.69-0.06-0.27-0.18-0.53
-0.350.33-0.540.280.120.520.26-0.54-0.730.350.220.550.290.420.63-0.20.25-0.55-0.410.60.680.520.93
0.65-0.070.780.03-0.260.25-0.660.740.640.29-0.160.390.43-0.8-0.71-0.30.290.69-0.410.15-0.24-0.19-0.43
0.410.61-0.10.440.160.78-0.150.11-0.310.870.460.680.880.050.16-0.120.23-0.060.60.150.840.680.45
0.170.82-0.310.60.430.560.21-0.15-0.550.70.690.440.530.320.4-0.070.22-0.270.68-0.240.840.930.51
0.210.8-0.230.590.430.40.17-0.15-0.50.560.650.360.330.170.3-0.170.24-0.180.52-0.190.680.930.33
-0.460.25-0.570.290.210.320.27-0.59-0.690.10.210.380.180.470.67-0.20.29-0.530.93-0.430.450.510.33
Click cells to compare fundamentals

Pfizer Account Relationship Matchups

Pfizer fundamental ratios Accounts

201720182019202020212022 (projected)
Inventories7.58 B7.51 B8.28 B8.05 B9.06 B7.92 B
Receivables8.22 B8.03 B8.72 B7.93 B11.48 B11.8 B
Accounts Payable4.66 B4.67 B4.22 B4.31 B5.58 B4.7 B
Accumulated Other Comprehensive Income(11.04 B)(9.32 B)(11.28 B)(11.64 B)(10.48 B)(11.3 B)
Total Assets171.8 B159.42 B167.49 B154.23 B181.48 B196.04 B
Current Assets41.14 B49.93 B32.8 B35.07 B59.69 B60.12 B
Assets Non Current132.67 B130.66 B109.5 B134.69 B121.22 B117.09 B
Cash and Equivalents1.34 B1.14 B1.3 B1.78 B1.94 B2.71 B
Cash and Equivalents USD2.6 B1.34 B1.14 B1.3 B1.17 B1.21 B
Total Debt42.09 B43.49 B41.74 B52.15 B59.97 B55.81 B
Debt Current10.69 B9.95 B8.83 B16.2 B18.62 B20.09 B
Debt Non Current31.4 B33.54 B32.91 B35.95 B32.36 B31.27 B
Total Debt USD42.09 B43.49 B41.74 B52.15 B59.97 B55.81 B
Shareholders Equity71.31 B63.41 B63.14 B63.24 B77.2 B82.19 B
Shareholders Equity USD59.54 B71.31 B63.41 B63.14 B56.83 B60.95 B
Goodwill and Intangible Assets107.1 B104.69 B88.62 B94.02 B84.62 B84.29 B
Inventory6.78 B7.58 B7.51 B8.28 B7.45 B7.1 B
Investments22.37 B25.66 B20.46 B28.67 B25.8 B27.9 B
Investments Current15.26 B18.65 B17.69 B8.53 B7.67 B7.87 B
Investments Non Current7.12 B7.01 B2.77 B20.15 B18.13 B14.66 B
Total Liabilities100.49 B96.02 B104.34 B90.99 B104.28 B113.85 B
Current Liabilities30.43 B31.86 B37.3 B25.92 B42.67 B35.05 B
Liabilities Non Current80.66 B69.71 B63.81 B66.74 B60.06 B62.82 B
Trade and Non Trade Payables4.54 B4.66 B4.67 B4.22 B4.85 B4.82 B
Property Plant and Equipment Net13.32 B13.87 B13.38 B13.97 B12.57 B12.86 B
Trade and Non Trade Receivables8.22 B8.22 B8.03 B8.72 B7.85 B8.38 B
Accumulated Retained Earnings Deficit71.77 B85.29 B89.55 B97.67 B112.32 B98.16 B
Tax Assets4.85 B4.91 B5.3 B5.44 B4.9 B5.79 B
Tax Liabilities35.19 B23.07 B19.7 B18.68 B16.82 B20.51 B

Be your own money manager

Our tools can tell you how much better you can do entering a position in Pfizer without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Currently Active Assets on Macroaxis

Please check Your Equity Center. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.76
Market Capitalization
277.1 B
Quarterly Revenue Growth YOY
0.46
Return On Assets
0.12
Return On Equity
0.34
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.